Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MAGE-Like 2 anticorps

Cet anticorps Lapin Polyclonal détecte spécifiquement MAGE-Like 2 dans ELISA et WB. Il présente une réactivité envers Humain, Souris et Rat.
N° du produit ABIN2433343

Aperçu rapide pour MAGE-Like 2 anticorps (ABIN2433343)

Antigène

Voir toutes MAGE-Like 2 (MAGEL2) Anticorps
MAGE-Like 2 (MAGEL2)

Reactivité

  • 33
  • 2
  • 2
  • 2
  • 2
  • 1
Humain, Souris, Rat

Hôte

  • 33
  • 1
Lapin

Clonalité

  • 33
  • 1
Polyclonal

Conjugué

  • 9
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MAGE-Like 2 est non-conjugé

Application

  • 13
  • 13
  • 11
  • 8
  • 7
  • 5
  • 3
  • 1
  • 1
ELISA, Western Blotting (WB)
  • Purification

    Antigen affinity purification

    Immunogène

    Synthetic peptide of human MAGEL2

    Isotype

    IgG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Conseil sur la manipulation

    Avoid freeze / thaw cycles.

    Stock

    -20 °C/-80 °C

    Stockage commentaire

    Store at -20°C (regular) and -80°C (long term).
  • Antigène

    MAGE-Like 2 (MAGEL2)

    Autre désignation

    MAGEL2

    Sujet

    Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13 region. Affected individuals exhibit neonatal hypotonia, developmental delay, and childhood-onset obesity. Necdin (NDN), a gene involved in the terminal differentiation of neurons, localizes to this region of the genome and has been implicated as one of the genes responsible for the etiology of PWS. This gene is structurally similar to NDN, is also localized to the PWS chromosomal region, and is paternally imprinted, suggesting a possible role for it in PWS.
    Synonyms: PWLS, nM15, NDNL1

    Poids moléculaire

    Calculated MW: 59 kDa
Vous êtes ici:
Chat with us!